Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | SELP | P16109 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | MMP9 | P14780 | 1/20 | 0.30 |
| ▸ | MMP12 | P39900 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12767266 | 1.00 | L3MBTL1 (0.52) | L3MBTL1KMT2AALDH1A1MEN1PKM | |
| SCHEMBL14468744 | 0.89 | L3MBTL1 (0.59) | L3MBTL1KMT2AALDH1A1MEN1PKM | |
| SCHEMBL21394611 | 0.89 | L3MBTL1 (0.59) | L3MBTL1KMT2AALDH1A1MEN1PKM | |
| SCHEMBL8058114 | 0.89 | L3MBTL1 (0.59) | L3MBTL1KMT2AALDH1A1MEN1PKM | |
| SCHEMBL13646611 | 0.89 | L3MBTL1 (0.59) | L3MBTL1KMT2AALDH1A1MEN1PKM | |
| SCHEMBL21381181 | 0.89 | L3MBTL1 (0.59) | L3MBTL1KMT2AALDH1A1MEN1PKM | |
| SCHEMBL13650802 | 0.89 | L3MBTL1 (0.59) | L3MBTL1KMT2AALDH1A1MEN1PKM | |
| SCHEMBL12767264 | 0.88 | L3MBTL1 (0.54) | L3MBTL1KMT2AALDH1A1MEN1PKM | |
| SCHEMBL12767245 | 0.88 | L3MBTL1 (0.54) | L3MBTL1KMT2AALDH1A1MEN1PKM | |
| SCHEMBL14355284 | 0.83 | L3MBTL1 (0.56) | L3MBTL1KMT2AALDH1A1MEN1PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8816050-B2 | Method of preparing glycopeptides | THE SCRIPPS RESEARCH INSTITUTE | 2014-08-26 | — | — | US | disclosed |
| US-20110060121-A1 | METHOD OF PREPARING GLYCOPEPTIDES | THE SCRIPPS RESEARCH INSTITUTE (US) | 2011-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110060121-A1 | METHOD OF PREPARING GLYCOPEPTIDES | PTMS, OGT, FUT6 | L3MBTL1 1394/4885KMT2A 3103/4885ALDH1A1 2902/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.